The pharmacovigilance industry is experiencing robust momentum driven by increasing regulatory scrutiny and the rising need for drug safety monitoring. Recent advancements in data analytics and AI integration have propelled the pharmacovigilance market trends, influencing industry size and business growth globally. This dynamic market is witnessing shifting market dynamics with evolving compliance frameworks and expanding market segments.

Market Size and Overview
The Global Pharmacovigilance Market size is estimated to be valued USD 14.03 Bn by 2032 and is expected to reach USD 14.03 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 8.3% from 2025 to 2032.

This Pharmacovigilance Market Growth reflects strong market growth driven by growing drug pipeline complexity and emphasis on patient safety. Increasing adoption of real-world data and electronic health records is expanding the market scope and creating new market opportunities. Regulatory initiatives worldwide are also key market drivers impacting pharmacovigilance market revenue and market share expansion.

Get more insights on - Pharmacovigilance Market